Project Grant R03AG081785

Award Date 8/15/24
Completion Date 7/31/26
Dollars Obligated $199K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Providence, RI 02912, USA
Similar Awards
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to study the impact of hospice care on the well-being of Alzheimer's disease (AD) patients and their family members. The $318,416 project will leverage natural experiments from the opening of new hospice facilities to estimate the effects of hospice utilization on patient outcomes such as pain management, depression, and activities of daily living. It will...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $608,731 to Brown University to study the impact of Medicare and Medicaid financial policies on post-acute and long-term care utilization and outcomes for persons living with Alzheimer's disease and related dementias (ADRD). The 5-year project aims to leverage Medicare claims and clinical assessment data to examine: 1) changes in nursing home and home health service use by ADRD patients amid...
The National Institute on Aging (NIA) awarded a $596,258 Project Grant (CFDA 93.866 - Aging Research) to Weill Medical College of Cornell University to characterize and predict patient trajectories after live discharge from hospice among older adults with Alzheimer's disease and related dementias (ADRD). The project aims to apply longitudinal clustering methods to Medicare claims and encounter data to identify patient subgroups with heterogeneous trajectories after hospice live discharge,...
The National Institute on Aging (NIA) awarded a Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to the University of Oklahoma Health Sciences Center to examine end-of-life care for persons living with dementia (PLWD). The $2,303,477 grant will leverage data from the Dementia Care Study (D-CARE), a 4-site randomized clinical trial, to compare documentation of PLWD advance care preferences, overall end-of-life care quality, and healthcare utilization in the last 6 months...
This $1,306,862 Project Grant awarded by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) will fund research on the relationship between real estate investment trust (REIT) investments in nursing homes and the quality of end-of-life care for residents with Alzheimer's disease and related dementias. The project, led by Weill Medical College of Cornell University, will construct a nationally representative database of nursing home residents with...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $584,820 to support a 5-year research study led by Dr. Whitley Aamodt at the University of Pennsylvania. The goal is to improve end-of-life (EOL) care quality for hospitalized patients with Lewy body disorders, a type of Alzheimer's disease and related dementia (ADRD). The project has two key objectives: 1) develop a risk prediction model to identify patients at high risk of 6-month mortality,...
This Project Grant award of $2,763,221 from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to examine the impact of physician, hospital, and skilled-nursing facility factors related to geriatric care on days spent at home among persons with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The study, conducted by Cedars-Sinai Medical Center, will use Medicare data linked to other nationally representative...
This $917,701 federal Project Grant award under the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a 5-year study conducted by Brigham & Women's Hospital to implement and evaluate an Acute Hospital Care at Home (AHCAH) pathway specifically for people living with dementia. The study aims to: 1) Evaluate the effect of a pre-enrollment AHCAH pathway on quality of life over 12 months for persons with moderate to severe dementia (Aim 1); and 2) Evaluate the...
This Federal Project Grant award of $319,000 from the National Institute on Aging (CFDA 93.866 - Aging Research) to Brown University will examine rural-urban disparities in Alzheimer's disease and related dementias across the United States. The key products or services to be delivered under this 2-year award include: Producing novel and robust estimates of dementia prevalence in rural and urban areas of the U.S. Characterizing the types of rural places and people most affected by dementia. The...
This $680,931 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a comprehensive research study to address disparities in nursing home care for people with serious mental illness (SMI) and Alzheimer's disease/related dementias (AD/ADRD). The key objectives are to: 1) Assess longitudinal patterns of SMI, AD/ADRD, and comorbid prevalence in nursing homes, including differences by race/ethnicity; 2) Estimate quality of life and quality of care...

The National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) Federal Grant Program, awarded a $199,375 project grant to Brown University. The project aims to examine whether hospices specializing in long-term care (LTC) settings provide better care to beneficiaries with Alzheimer's and related dementias (ADRD) compared to non-LTC hospices. Key objectives include: 1) describing individual, facility, and neighborhood-level characteristics associated with receiving care from LTC hospices, and 2) comparing quality outcomes between ADRD beneficiaries who receive care from LTC hospices versus non-LTC hospices using difference-in-difference analysis. The project leverages national claims data to generate empirical evidence on how hospice program specialization impacts the quality of care for ADRD beneficiaries. This research represents the first step in a larger effort to examine the impact of recent policy changes and market shifts on the quality of hospice care delivered to ADRD beneficiaries.

Generated 7/15/25, 3:52 AM